Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1673.55
4.35 (0.26%)
< Home < Back

Sun Pharmaceutical Industries informs about update

Date: 27-05-2023

In connection with its earnings call held on May 26, 2023, Sun Pharmaceutical Industries has informed that Global Ilumya sales for FY23 were US$ 477 million, up by about 51% as compared to FY22.

The above information is a part of company’s filings submitted to BSE.